Enfermedad hiperprogresiva en pacientes con CPNM avanzado tratados con inhibidores PD-1 / PD-L1

Entrevista con Benjamin Besse, MD, autor de «Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy».

Fuente: JAMA Oncology | September 6, 2018 | Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors
Enlace: Hyperprogressive Disease in Patients With Advanced NSCLC Treated With PD-1/PD-L1 Inhibitors